Skip to main content
Clinical Trials/JPRN-UMIN000016980
JPRN-UMIN000016980Not yet recruitingPhase 1

Effects of nattokinase on the patients with eosinophilic chronic rhinosinusitis - Effects of nattokinase on the patients with eosinophilic chronic rhinosinusitis

niversity of Fukui0 sites320 target enrollmentStarted: April 1, 2015Last updated:
Conditions

Trial Snapshot

Phase
Phase 1
Status
Not yet recruiting
Sponsor
Enrollment
320

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
15years-old to ot applicable (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1)The patient who is complicated with a nose disease (severe septum deviation, severe allergic rhinitis, nose or paranasal sinus tumor) that make this study difficult. 2)The case that the steroid dosage cannot cancel for the treatment of this disease and other diseases. 3)The case that has allergy for Natto or soybean. 4)Under during the pregnancy or the nursing 5)Patient during medical treatment of immunity 6)The patient who judged that the medical attendant was inappropriate

Investigators

Sponsor
niversity of Fukui

Similar Trials